September 6, 2016 / 12:50 PM / 2 years ago

BRIEF-Allergan acquires gene therapy company Retrosense Therapeutics

Sept 6 (Reuters) - Allergan Plc :

* Allergan Acquires Gene Therapy Company Retrosense Therapeutics Adding First-In-Class technology to company’s innovative eye care pipeline

* Says under terms of transaction, Allergan has paid Retrosense a $60 million upfront payment

* Says also has agreed to potential regulatory and commercialization milestone payments related to rst-001

* Says acquired substantially all of assets of Retrosense in an all-cash transaction Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below